MediciNova, Inc. (MNOV)
1.47
-0.03
(-2.00%)
USD |
NASDAQ |
Oct 14, 16:00
1.46
-0.01
(-0.68%)
Pre-Market: 20:00
MediciNova Total Long Term Debt (Quarterly) : 0.00 for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.0171M |
| September 30, 2025 | 0.0744M |
| June 30, 2025 | 0.117M |
| March 31, 2025 | 0.1652M |
| December 31, 2024 | 0.2115M |
| September 30, 2024 | 0.2552M |
| June 30, 2024 | 0.3025M |
| March 31, 2024 | 0.3512M |
| December 31, 2023 | 0.4107M |
| September 30, 2023 | 0.4638M |
| June 30, 2023 | 0.5197M |
| March 31, 2023 | 0.4894M |
| December 31, 2022 | 0.5236M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.6947M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.1826M |
| September 30, 2019 | 0.2393M |
| June 30, 2019 | 0.2788M |
| March 31, 2019 | 0.2359M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.0068M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 393.58M |
| Viking Therapeutics, Inc. | 3.925M |
| IDEAYA Biosciences, Inc. | 28.12M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |